Post-translational modifications in kidney diseases and associated cardiovascular risk

H Noels, V Jankowski, SJ Schunk… - Nature Reviews …, 2024 - nature.com
Patients with chronic kidney disease (CKD) are at an increased cardiovascular risk
compared with the general population, which is driven, at least in part, by mechanisms that …

Protein carbamylation and the risk of ESKD in patients with CKD

S Kalim, S Zhao, M Tang, EP Rhee… - Journal of the …, 2023 - journals.lww.com
Background Protein carbamylation, a post-translational protein modification partially driven
by elevated blood urea levels, associates with adverse outcomes in ESKD. However, little is …

[HTML][HTML] Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients

Z Saeed, V Sirolli, M Bonomini, S Gallina… - International Journal of …, 2024 - mdpi.com
Chronic kidney disease (CKD) is a global health issue causing a significant health burden.
CKD patients develop thrombotic and hemorrhagic complications, and cardiovascular …

[HTML][HTML] Carbamylation is instrumental in end-stage kidney disease coagulopathies: the impact on von Willebrand factor and platelet functionality

J Babickova, U Kałucka… - Thrombosis and …, 2024 - thieme-connect.com
Background Chronic kidney disease (CKD) is a progressive, irreversible, and incurable
condition characterized by high morbidity and mortality, affecting approximately one-tenth of …

Thrombozytenstörungen bei Urämie

CC Baaten, S Vondenhoff, J Jankowski, H Noels - Die Nephrologie, 2023 - Springer
Chronisch niereninsuffiziente Patienten (CKD [„chronic kidney disease “]-Patienten) haben
ein erhöhtes Risiko für kardiovaskuläre Erkrankungen („cardiovascular disease “; CVD) und …